Skip to Content

Workers’ Compensation Board

Search menu

Save the Date – COVID-19 and Workers’ Compensation Webinar

Subject Number 046-686 Temporary Suspension of Dr. Peter Liepmann's Authorization to Treat Injured Workers Effective May 15, 2014

Subject Numbers Regarding Health Provider Authorizations

Authorization No. 159061-1W

May 16, 2014

Pursuant to Workers' Compensation Law Section 13-d(4), the Chair of the New York State Workers' Compensation Board has exercised his authority to temporarily suspend Dr. Peter Liepmann's authorization to treat injured workers within the New York State workers' compensation system effective May 15, 2014. Dr. Liepmann's last known business address is 118 Main Street, Saranac Lake, NY 12983.

The Chair's designee's investigation revealed that the Department of Health, Bureau of Professional Medical Conduct (BPMC) issued BPMC Order # 13-323, wherein, Dr. Liepmann admitted guilt to the charge of negligence on more than one occasion. Dr. Liepmann's license has been suspended for two years, stayed with probation for two years. He also must provide 90 days' notice before practicing medicine in New York State or in any other jurisdiction where the practice of medicine is predicated on his New York State medical license, after which his practice may be subject to conditions. During probation, Dr. Liepmann may only practice medicine when his practice is being monitored by a licensed physician, board certified in an appropriate specialty.

Therefore, the Chair believes that Dr. Liepmann may be guilty of misconduct, and that such misconduct would detrimentally affect the quality of care provided to injured workers.

Dr. Liepmann is prohibited from rendering treatment and care to injured workers while his authorization is temporarily suspended. Reports submitted by Dr. Liepmann for services rendered prior to May 15, 2014, are valid, but are invalid for any services rendered on or after that date. Requests to cross-examine Dr. Liepmann for services rendered prior to May 15, 2014 should not be denied due to the suspension of his authorization.

This suspension remains in effect until further notice. Any questions regarding the authorized lists should be referred to the Medical Director’s Office at 1 (800) 781-2362.

Robert E. Beloten